Dexcom G7 sensors
Ended Awarded
- Contract number
- SPE2DB26FC1QD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,546.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,546.80 for DEXCOM G7 sensors under a firm fixed-price contract, with completion targeted for November 13, 2025. This non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999.999 billion through December 2026. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company's corporate office is headquartered.
AmerisourceBergen Drug Corp is one of the nation's leading pharmaceutical distributors and serves as a critical vendor within the federal medical supply chain, particularly for military and veteran healthcare systems. As a major pharmaceutical and medical device supplier, the company maintains an extensive portfolio of federal contracts with DLA covering a comprehensive range of products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for continuous glucose monitoring sensors reflects the company's role in supporting Defense Health Agency medical requirements and demonstrates the operational scope of the SPE2DX prime vendor contract, which enables flexible fulfillment of pharmaceutical and medical supply needs for global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FC1QD?
SPE2DB26FC1QD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DB26FC1QD worth?
The government has obligated $1,547 on SPE2DB26FC1QD.
Is contract SPE2DB26FC1QD an order under another contract?
Yes. SPE2DB26FC1QD is a delivery order under SPE2DB20D7066, an indefinite delivery contract.
Was contract SPE2DB26FC1QD competed?
The extent of competition for SPE2DB26FC1QD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award